Skip to content

ASD

GradeCNASDAQ Global Market

Defiance Autism Impact ETF

Themes · Defiance · Inception 2026-06-01

$26.92−0.49 (−1.78%)

As of Sep 23, 2026, 1:39 PM EDT

History starts Jun 2, 2026.History starts Jun 2, 2026.History starts Jun 2, 2026.
Intraday session: down, 3 prints from 27.41 to 26.92. Range 26.92 to 27.33. Use the arrow keys to read each point.$27.00$27.10$27.20$27.3010 AM12 PM2 PM4 PM
Expense ratio
0.79%
Fund size
$1M
1Y return
Yield · Last 12 months
Data unavailable
Holdings
40
Volume · 30D
0M sh
NAV per share
$27.22
52W range
low $24.59high $28.52

The ETF.net ASD Grade

C

40/ 100

Rank 12 of 21 in Global Thematic

Confidence Medium

Six-pillar profile for ASD. Scores out of 100: Cost 10, Risk 97, Mission not scored, Tradability 28, Holdings 78, Durability 30. Strongest: Risk (97). Weakest: Cost (10). Based on 5 of 6 pillars.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 40 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E. A structural cap ceilings this fund at 40, so B and A are out of reach.

Ceiling 40 · B and A out of reach

The pillars earned41This cap took1Published score40 Grade C
  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    FScore 10
    Category rank19/21 · bottom quartile
  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    Not scored
  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    AScore 97
    Category rank1/20 · top 5%
  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    DScore 28
    Category rank18/21 · bottom quartile
  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    AScore 78
    Category rank4/18 · top 22%
  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    DScore 30
    Category rank19/21 · bottom quartile

Graded as of Sep 22, 2026 · Based on 5 of 6 pillars

Our read on ASD

ETF.net Research

CThe first US-listed ETF built around the autism ecosystem: roughly 40 developed-market names in therapeutics, diagnostics and specialized education, equally weighted. Defiance pledges the fund's advisory profits to autism causes.

Stated mandate

The fund seeks to track, before fees and expenses, the total return of the VettaFi Autism Impact Index.

Why people hold it

  1. 01Rare mandate: an equal-weighted basket spanning autism therapeutics, diagnostics and assessment tools, and specialized education tech, so no single name dominates.defianceetfs.com
  2. 02Defiance has committed to donate 100% of its net advisory profits from the fund for its first two years, and no less than 50% after that, to autism care and research groups.defianceetfs.com
  3. 03Conventional plumbing under an unconventional theme: a 1940 Act fund tracking a published index, reconstituted semiannually and rebalanced quarterly.defianceetfs.com

Worth knowing

  1. 01At 0.79% a year it costs more than the typical global thematic fund; broader peers such as AGNG (0.50%) and FITE (0.45%) charge less for their baskets.
  2. 02Launched in 2026 and still small and thinly traded, which can mean wider bid-ask spreads than in the largest thematic funds.
  3. 03Roughly 40 names, mostly healthcare, so it moves with drug, diagnostics and behavioral-care sentiment more than with the broad market.

ASD Holdings

As of Sep 20, 2026, 5:08 AM
Asset class
Stocks
Holdings
40
Top-10 weight
75%
Largest holding
First American Government Obligations Fund 12/01/203150.4%

Geography

The fund’s holdings, weight-ordered — page 1 of 3.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001First American Government Obligations Fund 12/01/203150.38%684,723$685K625
002PKIRevvity Inc3.08%292$42K107
003RGENRepligen Corp2.81%216$38K150
0044502.TTakeda Pharmaceutical Co Ltd2.79%1,000$38K146
005TEVA.TATeva Pharmaceutical Industries Ltd2.79%962$38K79
006MCOV-B.STMedicover AB2.78%1,446$38K40
007LLYEli Lilly & Co2.71%32$37K569
008GSK.LGSK PLC2.71%1,468$37K160
0094506.TSumitomo Pharma Co Ltd2.71%3,600$37K50
010GHCGraham Holdings Co2.69%32$37K132
011ABBVAbbVie Inc2.68%138$36K511
012ROP.SWRoche Holding AG2.68%84$36K196
013DFTXDefinium Therapeutics Inc2.67%934$36K66
014JNJJohnson & Johnson2.66%134$36K521
015BFAMBright Horizons Family Solutions Inc2.65%548$36K116

Showing 1–15 of 39 holdings

ASD Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

ASD$10,909
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$10,415
Jun 22, 2026 to Sep 22, 2026. ASD $10,909. SPY $10,415. Use the arrow keys to read each point.$9,668$10,572$11,476Jun 2026Aug 2026Sep 2026

Jun 22, 2026 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for ASD. Periods over one year show the average yearly return.
PeriodASD
Year to dateFund launched this year
1 month−3.0%
3 months+9.1%
1 yearFund is under 1 year old
3 yearsFund is under 3 years oldper year
5 yearsFund is under 5 years oldper year
10 yearsFund is under 10 years oldper year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for ASD
YearReturn barASD
2026 YTD+11.4%

History from Jun 2, 2026

ASD in the news

ETF.net Research hasn’t filed on ASD yet — coverage lands here as it’s written.

ASD Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
Data unavailableLast 12 months
Payout per share
Data unavailableLast 12 months
Last payment
$0.006 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution data unavailable.

Distribution history

2026

One bar per payment. 1 payment in 2026 YTD. Jun 24, 2026 $0.006. Use the arrow keys to read each point.2026YTD
Ex-datePay dateAmount per share
Jun 24, 2026Jun 25, 2026$0.006

ASD Risk

How much the fund’s monthly returns vary, scaled to a year.
Launched Jun 2026; fills in after 12 months
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
Launched Jun 2026; fills in after 12 months
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
Launched Jun 2026; fills in after 12 months
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.31
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

ASD Cost

Expense ratio0.79%
  • The middle half of Global Thematic funds
  • Median 0.58%

18 of the 21 Global Thematic funds charge less.

ASD costs $79.00 a year on $10,000. The median Global Thematic fund costs $58.00.